I support fast-tracking drugs for serious diseases that don't currently have other approved options. Hopefully, FDA focuses on safety in these cases. If safety data is acceptable and efficacy data is not the best (but shows potential), they should be fast-tracked to market. IMHO
-
-
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
Nuplazid was approved April 2016.
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.